StockMarketWire.com - Specialist pharmaceuticals company N4 Pharma said it had raised £1.1m via a share issue to fund the development of its delivery system for vaccines and cancer therapeutics.

News shares in the company were issued at 0.4p each.

'We have made continued progress with Nuvec and believe that it has the potential to significantly improve patient outcomes and generate value for investors and partners,' chief executive Nigel Theobald said.


At 1:26pm: (LON:N4P) N4 Pharma Plc Ord 0.4p share price was -2.3p at 10.05p



Story provided by StockMarketWire.com